Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Best suited for immune and antioxidant support
If youre concerned about blood thinning or have conditions related to blood clotting, consult a healthcare professional
As of September 2023 it is on the FDA Category 2 list of bulk drug substances that may not be compounded, and a PCAC review is scheduled for July 2026 under the name Emideltide
& Hall M
Further research, including controlled studies with proper single-compound comparison groups, is needed to validate any combined effect
While some rat studies raised initial worries, none have shown that BPC-157 directly causes or speeds up cancer development
US$ 21.50
US$ 21.78
US$ 22.80
US$ 21.13
US$ 24.77
US$ 28.56
